Charmaine Henry, APRN | |
15511 N Florida Ave Ste 401, Tampa, FL 33613-1220 | |
(813) 963-3124 | |
(813) 908-7808 |
Full Name | Charmaine Henry |
---|---|
Gender | Female |
Speciality | Nurse Practitioner |
Experience | 16 Years |
Location | 15511 N Florida Ave Ste 401, Tampa, Florida |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003066713 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363LF0000X | Nurse Practitioner - Family | APRN2875992 (Florida) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Mendocino Coast District Hospital | Fort bragg, CA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Adventist Health Mendocino Coast | 3678990769 | 60 |
News Archive
A team led by researchers at Albert Einstein College of Medicine of Yeshiva University has found a clear link between living to 100 and inheriting a hyperactive version of an enzyme that rebuilds telomeres - the tip ends of chromosomes. The findings appear in the latest issue of the Proceedings of the National Academy of Sciences.
BD, a leading global medical technology company, will introduce its latest advancement in end-to-end IV safety, the new BD Cato™ ReadyMed solution — a digital solution that integrates with BD Cato, designed to help hospitals optimize the IV chemotherapy administration process by simplifying workflows and providing medication visibility with the ability to track the medication's journey to the patient.
The Texas House on Wednesday voted 135-2 to pass ( HB 1098 ) a Senate-approved bill that would prevent mandatory vaccination for middle school girls in the state until 2011, the New York Times reports (Blumenthal, New York Times , 4/26).
Increasing the level of a protein that plays a key role in traumatic spinal cord injuries and multiple sclerosis reduces the concentration of disease-causing plaque in Alzheimer's disease, Yale School of Medicine researchers report in the Journal of Neuroscience.
The combination of the immunotherapy drug ipilimumab and the investigational antibody drug nivolumab led to long-lasting tumor shrinkage in more than half of patients with metastatic melanoma, according to results from a Phase I trial simultaneously published online on Sunday, June 2, in The New England Journal of Medicine and presented by Memorial Sloan-Kettering Cancer Center researchers at the 49th Annual Meeting of the American Society of Clinical Oncology (ASCO).
› Verified 4 days ago
Entity Name | Adventist Health Mendocino Coast |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1538113725 PECOS PAC ID: 3678990769 Enrollment ID: O20220620001667 |
News Archive
A team led by researchers at Albert Einstein College of Medicine of Yeshiva University has found a clear link between living to 100 and inheriting a hyperactive version of an enzyme that rebuilds telomeres - the tip ends of chromosomes. The findings appear in the latest issue of the Proceedings of the National Academy of Sciences.
BD, a leading global medical technology company, will introduce its latest advancement in end-to-end IV safety, the new BD Cato™ ReadyMed solution — a digital solution that integrates with BD Cato, designed to help hospitals optimize the IV chemotherapy administration process by simplifying workflows and providing medication visibility with the ability to track the medication's journey to the patient.
The Texas House on Wednesday voted 135-2 to pass ( HB 1098 ) a Senate-approved bill that would prevent mandatory vaccination for middle school girls in the state until 2011, the New York Times reports (Blumenthal, New York Times , 4/26).
Increasing the level of a protein that plays a key role in traumatic spinal cord injuries and multiple sclerosis reduces the concentration of disease-causing plaque in Alzheimer's disease, Yale School of Medicine researchers report in the Journal of Neuroscience.
The combination of the immunotherapy drug ipilimumab and the investigational antibody drug nivolumab led to long-lasting tumor shrinkage in more than half of patients with metastatic melanoma, according to results from a Phase I trial simultaneously published online on Sunday, June 2, in The New England Journal of Medicine and presented by Memorial Sloan-Kettering Cancer Center researchers at the 49th Annual Meeting of the American Society of Clinical Oncology (ASCO).
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Charmaine Henry, APRN 15511 N Florida Ave Ste 401, Tampa, FL 33613-1220 Ph: (813) 963-3124 | Charmaine Henry, APRN 15511 N Florida Ave Ste 401, Tampa, FL 33613-1220 Ph: (813) 963-3124 |
News Archive
A team led by researchers at Albert Einstein College of Medicine of Yeshiva University has found a clear link between living to 100 and inheriting a hyperactive version of an enzyme that rebuilds telomeres - the tip ends of chromosomes. The findings appear in the latest issue of the Proceedings of the National Academy of Sciences.
BD, a leading global medical technology company, will introduce its latest advancement in end-to-end IV safety, the new BD Cato™ ReadyMed solution — a digital solution that integrates with BD Cato, designed to help hospitals optimize the IV chemotherapy administration process by simplifying workflows and providing medication visibility with the ability to track the medication's journey to the patient.
The Texas House on Wednesday voted 135-2 to pass ( HB 1098 ) a Senate-approved bill that would prevent mandatory vaccination for middle school girls in the state until 2011, the New York Times reports (Blumenthal, New York Times , 4/26).
Increasing the level of a protein that plays a key role in traumatic spinal cord injuries and multiple sclerosis reduces the concentration of disease-causing plaque in Alzheimer's disease, Yale School of Medicine researchers report in the Journal of Neuroscience.
The combination of the immunotherapy drug ipilimumab and the investigational antibody drug nivolumab led to long-lasting tumor shrinkage in more than half of patients with metastatic melanoma, according to results from a Phase I trial simultaneously published online on Sunday, June 2, in The New England Journal of Medicine and presented by Memorial Sloan-Kettering Cancer Center researchers at the 49th Annual Meeting of the American Society of Clinical Oncology (ASCO).
› Verified 4 days ago
Ms. Bridget Shoulders-odom, MS, ACNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 13000 Bruce B Downs Bld, Tampa, FL 33612 Phone: 813-972-2000 | |
Ms. Rhea Arlene Hurwitz, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 3001 W Martin Luther King Boulevard, Tampa, FL 33607 Phone: 813-554-8511 | |
Dr. Leigh Nicole Montejo, DNP, FNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 9527 Delaney Creek Blvd, Tampa, FL 33619 Phone: 813-615-5230 | |
Mrs. Dawn Elizabeth White, NP-C Nurse Practitioner Medicare: May Accept Medicare Assignments Practice Location: 2901 W Saint Isabel St, Suite A3, Tampa, FL 33607 Phone: 813-872-4401 | |
Crystal Elaine Blair, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 13000 Bruce B Downs Blvd, Tampa, FL 33612 Phone: 813-972-2000 | |
Courtney Pariso, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3010 E 138th Ave, Suite 12, Tampa, FL 33613 Phone: 813-975-2800 Fax: 813-977-7631 |